<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Weiss SL</submitter><funding>NICHD NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>e0360</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7994045</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>3(3)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>The intestinal microbiome can modulate immune function through production of microbial-derived short-chain fatty acids. We explored whether intestinal dysbiosis in children with sepsis leads to changes in microbial-derived short-chain fatty acids in plasma and stool that are associated with immunometabolic dysfunction in peripheral blood mononuclear cells.&lt;h4>Design&lt;/h4>Prospective observational pilot study.&lt;h4>Setting&lt;/h4>Single academic PICU.&lt;h4>Patients&lt;/h4>Forty-three children with sepsis/septic shock and 44 healthy controls.&lt;h4>Measurements and main results&lt;/h4>Stool and plasma samples were serially collected for sepsis patients; stool was collected once for controls. The intestinal microbiome was assessed using 16S ribosomal RNA sequencing and alpha- and beta-diver</pubmed_abstract><journal>Critical care explorations</journal><pubmed_title>Decreased Intestinal Microbiome Diversity in Pediatric Sepsis: A Conceptual Framework for Intestinal Dysbiosis to Influence Immunometabolic Function.</pubmed_title><pmcid>PMC7994045</pmcid><funding_grant_id>R01 MH108592</funding_grant_id><funding_grant_id>K23 GM110496</funding_grant_id><funding_grant_id>K12 HD047349</funding_grant_id><funding_grant_id>R01 OD010944</funding_grant_id><funding_grant_id>R01 NS021328</funding_grant_id><pubmed_authors>Wu GD</pubmed_authors><pubmed_authors>Mattei LM</pubmed_authors><pubmed_authors>Bushman FD</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>McGowan FX</pubmed_authors><pubmed_authors>Balamuth F</pubmed_authors><pubmed_authors>Collman RG</pubmed_authors><pubmed_authors>Bittinger K</pubmed_authors><pubmed_authors>Wallace DC</pubmed_authors><pubmed_authors>Friedman ES</pubmed_authors><pubmed_authors>Graham K</pubmed_authors><pubmed_authors>Weiss SL</pubmed_authors><pubmed_authors>Baldassano RN</pubmed_authors><pubmed_authors>Bush J</pubmed_authors><pubmed_authors>Lee JJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Decreased Intestinal Microbiome Diversity in Pediatric Sepsis: A Conceptual Framework for Intestinal Dysbiosis to Influence Immunometabolic Function.</name><description>&lt;h4>Objectives&lt;/h4>The intestinal microbiome can modulate immune function through production of microbial-derived short-chain fatty acids. We explored whether intestinal dysbiosis in children with sepsis leads to changes in microbial-derived short-chain fatty acids in plasma and stool that are associated with immunometabolic dysfunction in peripheral blood mononuclear cells.&lt;h4>Design&lt;/h4>Prospective observational pilot study.&lt;h4>Setting&lt;/h4>Single academic PICU.&lt;h4>Patients&lt;/h4>Forty-three children with sepsis/septic shock and 44 healthy controls.&lt;h4>Measurements and main results&lt;/h4>Stool and plasma samples were serially collected for sepsis patients; stool was collected once for controls. The intestinal microbiome was assessed using 16S ribosomal RNA sequencing and alpha- and beta-diver</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2026-03-18T13:43:48.429Z</modification><creation>2025-04-04T11:43:48.101Z</creation></dates><accession>S-EPMC7994045</accession><cross_references><pubmed>33786436</pubmed><doi>10.1097/CCE.0000000000000360</doi></cross_references></HashMap>